1. ALLA AKTIER
  2. NYHETER
  3. SIMRIS ALG

Simris Alg

Nyheter Simris Alg Nyheter alla bolag

SIMRIS GROUP BROUGHT FORWARD INTERIM REPORT FOR QUARTER 2

MARKN.

Simris Group hereby announces that the publication of the company's interim report for the second quarter of 2023, the period 1 January - 30 June 2023, will be brought forward to 24 July 2023 instead of 9 August 2023, which was previously stated in the Company's financial calendar.

The reason for bringing forward the interim report is to make the information available during the subscription period for the company's upcoming Rights Issue.

Contact Details:
Julian Read
CEO Simris Group AB
Email: ir@simris.com
Mobile: +46767888212
www.simrisgroup.com

About Simris Group AB (PUBL):
Simris Group is a biologics company identifying high value, natural, biologically active compounds found in microalgae and cyanobacteria to extract for applications in skincare, nutrition, and biopharmaceuticals. The company sustainably grows microalgae and cyanobacteria at industrial scale within its photobioreactor facility whereby conditions are optimized for production of these high-value compounds. 
Simris Group's shares are traded on the Nasdaq First North Growth Market with the short name SIMRIS and ISIN code SE0008091664.
Certified Adviser is Amudova AB, telephone: 08-546 017 58, email: info@amudova.se.

Attachments
SIMRIS GROUP BROUGHT FORWARD INTERIM REPORT FOR QUARTER 2

Datum 2023-07-05, kl 22:22
Källa MFN
Bifogade filer
SIMRIS GROUP BROUGHT FORWARD INTERIM REPORT FOR QUARTER 2
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!